Affordable FBS alternative Atlas specializes in EquaFetal, an alternative fetal bovine serum (FBS) that offers similar performance at a fraction of the cost, presenting a price-competitive entry point for customers looking to optimize biomanufacturing budgets.

Traceability and quality The company emphasizes end-to-end process control from farm to bottle, enabling clients to demand higher traceability and manufacturing standards for regulatory compliance and consistent experimental results.

Targeted biotech markets Current focus spans biomanufacturing, cell culture, life science research, medical devices, and diagnostics, indicating multiple near-term sales avenues with organizations needing dependable serum for scalable production and R&D.

Small team agility With a lean headcount, Atlas can leverage personalized outreach and rapid, hands-on customer support to win boutique or specialized labs that value customization and responsive service.

Revenue growth potential Reported revenue in the mid-range of tens of millions suggests expansion opportunities through new institutions, larger university programs, contract research organizations, and international distributors seeking reliable serum sources.